Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Dapagliflozin by Biotts for Type 2 Diabetes: Likelihood of Approval
Dapagliflozin is under clinical development by Biotts and currently in Phase I for Type 2 Diabetes. According to GlobalData, Phase...